The COVID-19 pandemic compelled governments worldwide to adopt emergency legislation to curb transmission and safeguard public health. Measures such as lockdowns, curfews, quarantines, and digital surveillance were implemented with varying degrees of necessity and proportionality. While these interventions mitigated disease spread, they frequently conflicted with human rights norms by restricting freedoms of movement, assembly, privacy, and expression. This paper examines the legal tensions between pandemic management and international human rights law, analysing the principles of derogation and limitation under instruments such as the International Covenant on Civil and Political Rights and regional conventions. Drawing on comparative jurisprudence and case studies, it evaluates how judicial and institutional oversight mediated between public health imperatives and civil liberties. The paper concludes by proposing normative principles to ensure that future pandemic legislation remains effective yet rights-compliant, grounded in legality, necessity, proportionality, and accountability. Keywords: pandemic; emergency powers; human rights; public health; proportionality; surveillance; accountability; data protection; non-derogable rights; judicial oversight; legislative review; global health governance

Abstract

This study evaluates public satisfaction with the free pharmaceutical provision system in Almaty, Kazakhstan, focusing on medication availability, communication strategies, and the equitable distribution of essential drugs to vulnerable populations. The research aims to identify systemic barriers and propose actionable solutions to improve the efficiency of free medication programs. A cross-sectional design was implemented, with data collected through structured interviews of 420 participants across 33 municipal polyclinics. A stratified random sampling method ensured balanced representation across gender, age, and social categories. Statistical analysis, including chi-square tests and logistic regression, identified key predictors of patient satisfaction and medication accessibility. Results revealed that nearly half of respondents experienced difficulties in obtaining essential medications, often due to lack of stock or refusal to fill prescriptions, with pensioners and individuals with disabilities being disproportionately affected. Despite high awareness of the program, supply chain issues and administrative hurdles were recurrent challenges. The study highlights the importance of realtime stock monitoring, improved communication channels, and targeted interventions for atrisk populations to enhance public trust and system effectiveness. The findings emphasize the need for tailored strategies to address urban healthcare dynamics, contributing to global discussions on universal health coverage and equitable access to essential medicines. This research is novel in its localized approach, providing insights that may inform both national and international policy frameworks for improving pharmaceutical access in urban contexts. Keywords: Pharmaceutical access, Universal health coverage, Urban healthcare equity, Patient satisfaction, Supply chain management